26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.
作者信息
Maron B J, Isner J M, McKenna W J
出版信息
Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S261-7.
PMID:7934749
Abstract
摘要
Zotero 插件